dddmag.com
Drug Discovery & Development  
  NEWSLETTERS      |      WHITE PAPERS      |      SUBSCRIBE      |      ADVERTISE      |      CONTACT US      |      ABOUT US    

  Today is: 

News
Life Science News
Pharma/Biotech News
Drug Discovery News
Drug Development News
Genomics and Proteomics News
Legal/Regulatory News
Business/Financial News
Supplier News






SITE SPONSORS 
Advertise with Us
 

Browse Business/Financial News:


MorphoSys And Absynth Sign Collaboration
MorphoSys has signed a license and collaboration agreement with UK-based Absynth Biologics, providing access to novel target molecules associated with Staphylococcus aureus infections including MRSA (methicillin-resistant S. aureus).  continue



 New Mountain Purchases Mallinckrodt Baker
An affiliate of New Mountain Capital, LLC announced the completion of its acquisition of Mallinckrodt Baker, Inc. from Covidien for approximately $280 million.  continue



 KYTHERA And Intendis Ink Potential $373M Deal
KYTHERA Biopharmaceuticals, Inc. and Intendis, Bayer HealthCare’s dermatology business, have entered into a licensing agreement granting Intendis rights to KYTHERA’s lead product candidate, ATX-101, outside of the US and Canada.  continue



 Genzyme Rebuffs Sanofi Buyout Bid
Biotechnology company Genzyme Corp. said it rejected Sanofi-Aventis SA's $18.5 billion buyout offer because it undervalues the company.  continue
Damian J. Troise


J&J CEO Acknowledges Loss of Public Trust
With Johnson & Johnson's once-golden reputation tarnished by 11 recalls of medicines, contact lenses, and hip implants in as many months, its chief executive says he knows the company let consumers down.  continue
Linda A. Johnson


Omni Announces Contract With University of Colorado
Omni Bio Pharmaceutical, Inc. has executed a two-year contract with the University of Colorado Denver-Anschutz Medical Campus to further evaluate the biological activity of Alpha-1 antitrypsin and its effects on influenza.  continue



 Ambry Adds HiSeq and BeadXpress Instruments
Ambry Genetics, a global leader in genomic services, announced that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System as well as received the first 510(K) approved Illumina BeadXpress Genotyping System.  continue



 Chindex Sells $14M Worth of Shares
Chindex International sold $14 million of its shares to another Chinese medical concern as part of its plans to form a new joint venture, the company said.  continue



 Edge And SurModics Collaborate on TBI Treatment
According to the agreement, SurModics will develop Edge Therapeutics' lead candidate, Nimogel, a novel biodegradable, site-specific, sustained-release formulation for treatment of delayed complications of ruptured brain aneurysms or traumatic brain injury.  continue



 IDBS Acquires Quantrix
IDBS, a worldwide provider of data management and analytics solutions to healthcare organizations, announced that it has concluded an agreement to acquire Quantrix, a company that provides business modeling and analytics software and services.  continue



Most Popular


  1. New Targets, Dual Agonists Increase Possibilities for Treating Diabetes

  2. New Research May Impact Treatment of MS

  3. Study Demonstrates Benefits of Cannabis for Pain

  4. Lilly Halts Disappointing Alzheimer's Treatment

  5. Jazz Pharma Drug Treats Fibromyalgia

  6. Berries Activate Brain's Housekeeping Mechanism

  7. Obama Stem Cell Regulations Temporarily Blocked

  8. J&J Appoints Quality Czar

  9. Botox Case Settled for $600M

  10. More Problems At J&J Subsidiary